Caspase inhibitor z-VAD-FMK increases the survival of hair cells after Actinomycin-D-induced damage in vitro

Neurosci Lett. 2020 Jul 27:732:135089. doi: 10.1016/j.neulet.2020.135089. Epub 2020 May 25.

Abstract

Actinomycin-D (Act-D) is a highly effective chemotherapeutic agent that induces apoptosis in systemic tissues. Act-D combined with other chemotherapeutic agents exhibits ototoxic effects and causes hearing impairment. To investigate the potential toxic effects of Act-D in the inner ear, we treated cochlear organotypic cultures with varying concentrations of Act-D for different durations. For the first time, we found that Act-D specifically induced HC loss and apoptosis in a dose- and time-dependent manner but not neuronal degeneration. Co-treatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (z-VAD-FMK), a pan cysteine protease inhibitor, significantly reduced HC loss and apoptosis induced by Act-D, indicating increased cell survival. Taken together, Act-D exposure has ototoxic effects on the auditory system, while z-VAD-FMK prevents Act-D-induced hair cell damage.

Keywords: Actinomycin-D; Apoptosis; Hair cells; Reactive oxygen species; Spiral ganglion neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Chloromethyl Ketones / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Caspase 3 / metabolism
  • Caspase Inhibitors
  • Cell Survival / drug effects
  • Cochlear Nerve / drug effects
  • Culture
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dactinomycin / toxicity*
  • Hair Cells, Auditory / drug effects*
  • Humans
  • Infant, Newborn
  • Organ of Corti / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species
  • Spiral Ganglion / drug effects

Substances

  • Amino Acid Chloromethyl Ketones
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Reactive Oxygen Species
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Dactinomycin
  • Caspase 3